OCT Imaging-Dr. Sambhara

#OCT has become one of the most important tools we use every single day. From its early days with time-domain scans to today’s spectral-domain and swept-source systems, the technology has completely changed how we diagnose and manage retinal disease. In this video, Dr. Deepak Sambhara explains why OCT is the most commonly ordered test in #ophthalmology and how its role is expanding beyond the clinic. OCTA in particular is opening new doors, not just for retinal vascular imaging, but even in #research on systemic conditions like Alzheimer’s. It’s a reminder that OCT isn’t just “pretty pictures.” It’s a window into #eyehealth, systemic health, and maybe the future of medicine itself. #retina #eyecare #retinasurgeon Financial Disclosures: Apellis, Astellas, Eclipse Life Sciences, Genentech, Heidelberg Engineering, Ocular Therapeutix and Regeneron.